$1.03
arrow_drop_up8.64%Key Stats | |
---|---|
Open | $0.95 |
Prev. Close | $0.94 |
EPS | -1.74 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $57.41M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 0.95 | 1.03 |
52 Week Range | 0.69 | 1.60 |
Ratios | |
---|---|
EPS | -1.74 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
10x Genomics (TXG) Reports Q2 Loss, Tops Revenue Estimates
Kronos Bio to Present Clinical Update on Phase 1/2 Trial of KB-0742 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
Kronos Bio to Participate in Three Upcoming Healthcare Conferences and Events
Kronos Bio Appoints Deborah Knobelman, Ph.D. as Chief Operating Officer and Chief Financial Officer
Down -5.63% in 4 Weeks, Here's Why Kronos Bio (KRON) Looks Ripe for a Turnaround
Kronos Bio, Inc. (KRON) Reports Q1 Loss, Tops Revenue Estimates